Sirio Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 5.92% vs 0.28% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -25.84% vs 4.82% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,003.30",
          "val2": "947.20",
          "chgp": "5.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.60",
          "val2": "148.60",
          "chgp": "-39.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "19.20",
          "val2": "24.40",
          "chgp": "-21.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "1.60",
          "chgp": "-162.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "41.90",
          "val2": "56.50",
          "chgp": "-25.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.30%",
          "val2": "84.50%",
          "chgp": "0.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.31% vs 17.47% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -92.77% vs 17.35% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,250.40",
          "val2": "4,195.60",
          "chgp": "1.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "539.90",
          "val2": "689.00",
          "chgp": "-21.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "106.20",
          "val2": "97.30",
          "chgp": "9.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-169.90",
          "val2": "-21.90",
          "chgp": "-675.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.40",
          "val2": "282.00",
          "chgp": "-92.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "59.90%",
          "val2": "95.50%",
          "chgp": "-3.56%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,003.30

947.20

5.92%

Operating Profit (PBDIT) excl Other Income

90.60

148.60

-39.03%

Interest

19.20

24.40

-21.31%

Exceptional Items

-1.00

1.60

-162.50%

Consolidate Net Profit

41.90

56.50

-25.84%

Operating Profit Margin (Excl OI)

90.30%

84.50%

0.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 5.92% vs 0.28% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -25.84% vs 4.82% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,250.40

4,195.60

1.31%

Operating Profit (PBDIT) excl Other Income

539.90

689.00

-21.64%

Interest

106.20

97.30

9.15%

Exceptional Items

-169.90

-21.90

-675.80%

Consolidate Net Profit

20.40

282.00

-92.77%

Operating Profit Margin (Excl OI)

59.90%

95.50%

-3.56%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 1.31% vs 17.47% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -92.77% vs 17.35% in Dec 2024

All Annual Results